OpenDNA launches direct-to-consumer genomic health site

OpenDNA has launched opendnahealth.com, giving consumers direct online access to genomic health testing and personalized risk insights without going through a clinic first. The move expands the company’s reach beyond healthcare providers and adds physician consultation to its consumer offering.

Why it matters: - OpenDNA's new consumer site opens direct access to personalized genomic health testing for people who want risk information without first visiting a provider. - The launch could broaden adoption of polygenic risk scores for cardiometabolic conditions, including coronary heart disease, obesity, type 2 diabetes, high cholesterol and hypertension. - The offering aims to turn genetic data into a clearer prevention plan and support more informed health decisions.

What happened: - OpenDNA launched opendnahealth.com, a direct-to-consumer website for genomic health products. - Consumers can use the site to learn about OpenDNA's products and technology and order online. - OpenDNA said its consumer offering is now available alongside the company's existing clinical products sold through healthcare providers across the U.S. - The company said the site is designed to give consumers a new way to access personalized genomic health information.

The details: - OpenDNA's genomic testing includes polygenic risk scores for cardiometabolic diseases. - The diseases covered include coronary heart disease, obesity, type 2 diabetes, high cholesterol and hypertension. - The consumer experience combines genomic analysis with OpenDNA's AI-powered technology. - The platform is designed to translate genetic information into a personalized prevention plan. - Consumers also can access a telemedicine consultation with a physician to review results and the prevention plan. - The website explains OpenDNA's technology, genomic health products and its approach to combining genomics, AI and clinical information. - OpenDNA's products are already offered through concierge medicine and primary care practices in the United States.

Between the lines: - The launch signals a shift from provider-led distribution to a hybrid model that includes direct consumer access. - Adding physician consultation may help the company position genetic testing as a health planning tool rather than a standalone result. - OpenDNA is trying to lower friction for consumers while keeping a clinical touchpoint in the experience.

What's next: - Consumers can now visit opendnahealth.com to explore the offering and order directly online. - OpenDNA is likely to use the new site to build awareness of its consumer and clinical products and expand access beyond provider channels. - The company says the platform is meant to help individuals and healthcare providers better understand genetic risk and support more personalized approaches to prevention.

The bottom line: - OpenDNA is betting that easier online access, AI-driven interpretation and doctor follow-up will make genomic risk testing more usable for everyday consumers.